Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

US Patent 11530231 · Granted Dec 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimitotic amides for the treatment of cancer and proliferative disorders2025
Alvocidib prodrugs having increased bioavailability2025
Process for preparing substituted pyrazolo[1,5-a]pyrazines2024
Carboxylic acid compounds2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
ALK-5 inhibitors and uses thereof2023